Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
25 studies found for:    FUS
Show Display Options
Rank Status Study
1 Completed Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer
Condition: Lung Cancer
Intervention: Genetic: DOTAP:Chol-fus1
2 Recruiting FUS1-nanoparticles and Erlotinib in Stage IV Lung Cancer
Condition: Lung Cancer
Interventions: Drug: DOTAP:Chol-fus1;   Drug: Erlotinib;   Drug: Dexamethasone;   Drug: Diphenhydramine
3 Unknown  Safety Study Using Transcranial MR Guided Focused Ultrasound in the Treatment of Neuropathic Pain
Condition: Functional Brain Disorders /Neuropathic Pain
Intervention: Device: ExAblate 4000 focused ultrasound brain intervention
4 Recruiting Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Brain Tumors
Condition: Malignant Brain Tumors
Intervention: Device: Non-invasive intervention with focused ultrasound (ExAblate 4000)
5 Completed Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future
Conditions: Uterine Fibroids;   Pregnancy
Intervention: Procedure: Magnetic Resonance Guided Focused Ultrasound
6 Enrolling by invitation SMS Reminder for Forgotten Ureteral Stents
Condition: Stents
Intervention:
7 Completed
Has Results
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.
Condition: Overactive Bladder
Interventions: Drug: Tolterodine ER;   Drug: Placebo;   Drug: Fesoterodine
8 Recruiting ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Device: ExAblate Transcranial System
9 Completed ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Metastatic Bone Tumors for the Palliation of Pain
Conditions: Bone Metastases;   Multiple Myeloma
Interventions: Device: ExAblate 2000;   Device: Sham
10 Recruiting ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors
Conditions: Glioma;   Metastatic Brain Cancer
Intervention: Device: ExAblate Transcranial System
11 Not yet recruiting ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Device: ExAblate Transcranial System
12 Completed ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) for Treatment of Tremor
Conditions: Tremor;   Essential Tremor
Intervention: Device: ExAblate Transcranial System
13 Not yet recruiting ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
Conditions: Movement Disorders;   Essential Tremor;   Holmes Tremor;   Parkinson's Disease;   Wilson's Disease;   Huntington's Disease;   Dystonia;   Tardive Dyskinesia;   Orofacial Dyskinesias
Intervention: Device: Transcranial ExAblate System
14 Completed Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders
Conditions: Essential Tremor;   Dystonia;   Parkinson's Disease
Intervention: Device: Non-invasive intervention with focused ultrasound (ExAblate 4000)
15 Terminated MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas
Condition: Breast Fibroadenoma
Intervention: Device: ExAblate 2000
16 Unknown  Study of ExAblate Focused Ultrasound Ablation of Breast Cancer
Condition: Breast Cancer
Intervention: Device: ExAblate MRgFUS
17 Recruiting Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
Conditions: Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   PLS;   Motor Neuron Disease;   Lou Gehrigs Disease;   Familial Disease;   Amyotrophic Lateral Sclerosis, Sporadic
Intervention:
18 Withdrawn Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn
Condition: Non Hodgkin's Lymphoma
Interventions: Drug: Fusilev;   Drug: Folotyn
19 Withdrawn Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Folotyn;   Drug: Fusilev
20 Withdrawn A Post-Market Study of Transfacet Lumbar Spine Fixation and Fusion Utilizing the PERPOS™ PLS System
Condition: Lumbar Facet Disease
Intervention: Device: PERPOS™ PLS

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Indicates status has not been verified in more than two years